50,000 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Acquired by State of Michigan Retirement System

State of Michigan Retirement System bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 50,000 shares of the exchange traded fund’s stock, valued at approximately $4,744,000. State of Michigan Retirement System owned 0.06% of SPDR S&P Biotech ETF at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Concourse Financial Group Securities Inc. boosted its position in SPDR S&P Biotech ETF by 21.2% during the fourth quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock valued at $59,000 after buying an additional 115 shares during the period. Verity Asset Management Inc. raised its stake in SPDR S&P Biotech ETF by 0.8% in the fourth quarter. Verity Asset Management Inc. now owns 17,368 shares of the exchange traded fund’s stock worth $1,551,000 after buying an additional 140 shares in the last quarter. Greenwich Wealth Management LLC raised its stake in SPDR S&P Biotech ETF by 1.4% in the fourth quarter. Greenwich Wealth Management LLC now owns 11,451 shares of the exchange traded fund’s stock worth $1,022,000 after buying an additional 155 shares in the last quarter. Mesirow Institutional Investment Management Inc. grew its holdings in SPDR S&P Biotech ETF by 3.2% in the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 5,565 shares of the exchange traded fund’s stock worth $497,000 after purchasing an additional 170 shares during the period. Finally, HB Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 4.9% in the fourth quarter. HB Wealth Management LLC now owns 4,280 shares of the exchange traded fund’s stock worth $382,000 after purchasing an additional 200 shares during the period.

SPDR S&P Biotech ETF Stock Down 1.8 %

NYSEARCA:XBI opened at $91.36 on Wednesday. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The company’s 50 day moving average price is $90.27 and its 200-day moving average price is $90.94. The stock has a market cap of $6.96 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.